Skip to Content

Cidofovir Injection

Last Updated: April 1, 2015
Status: Resolved

Products Affected - Description

Cidofovir injection, Heritage Pharmaceuticals
75 mg/mL, 5 mL vial, single count (NDC 23155-0216-31)

Reason for the Shortage

  • Gilead discontinued Vistide injection in July 2014.
  • Heritage could not provide a reason for the shortage. However, cidofovir injection is manufactured by Emcure for Heritage. An Emcure manufacturing site was recently noted to have FDA observations related to GMP and aseptic practices.

Available Products

Cidofovir injection, Mylan Institutional
75 mg/mL, 5 mL vial, single count (NDC 67457-0210-05)

Estimated Resupply Dates

Heritage has cidofovir injection temporarily unavailable and the company cannot estimate when product will return.

Related Shortages

Updated

April 1, March 11, January 14, 2015; November 19, November 10, October 13, September 15, August 29, August 1, July 3, May 12, March 14, January 8, 2014; November 6, September 25, August 22, July 29, June 24, June 6, May 1, April 3, March 29, February 15, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide